The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.

Saved in:
Bibliographic Details
Title: The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Authors: Kraemer AI; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Chong C; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Huber F; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Pak H; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Stevenson BJ; Agora Cancer Research Centre, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland., Müller M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland., Michaux J; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Altimiras ER; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland., Rusakiewicz S; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Simó-Riudalbas L; École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Planet E; École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Wiznerowicz M; International Institute for Molecular Oncology, Poznań, Poland.; Poznań University of Medical Sciences, Poznań, Poland., Dagher J; Department of Pathology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland., Trono D; École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; Agora Cancer Research Centre, Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Tissot S; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland., Bassani-Sternberg M; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. michal.bassani@chuv.ch.; Department of Oncology, Centre hospitalier universitaire vaudois, Lausanne, Switzerland. michal.bassani@chuv.ch.; Agora Cancer Research Centre, Lausanne, Switzerland. michal.bassani@chuv.ch.; Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. michal.bassani@chuv.ch.
Source: Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 608-628. Date of Electronic Publication: 2023 May 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-023-00548-5